Quality indicators of clinical cancer care for prostate cancer: a population-based study in southern Switzerland

BMC Cancer
Laura OrtelliAndrea Bordoni

Abstract

Quality of cancer care (QoCC) has become an important item for providers, regulators and purchasers of care worldwide. Aim of this study is to present the results of some evidence-based quality indicators (QI) for prostate cancer (PC) at the population-based level and to compare the outcomes with data available in the literature. The study included all PC diagnosed on a three years period analysis (01.01.2011-31.12.2013) in the population of Canton Ticino (Southern Switzerland) extracted from the Ticino Cancer Registry database. 13 QI, approved through the validated Delphi methodology, were calculated using the "available case" approach: 2 for diagnosis, 4 for pathology, 6 for treatment and 1 for outcome. The selection of the computed QI was based on the availability of medical documentation. QI are presented as proportion (%) with the corresponding 95% confidence interval. 700 PC were detected during the three-year period 2011-2013: 78.3% of them were diagnosed through a prostatic biopsy and for 72.5% 8 or more biopsy cores were taken. 46.5% of the low risk PC patients underwent active surveillance, while 69.2% of high risk PC underwent a radical treatment (radical prostatectomy, radiotherapy or brachytherapy) and 73.5% of pat...Continue Reading

References

Mar 29, 2000·British Journal of Cancer·J BullardJ Peto
Nov 10, 2000·Social Science & Medicine·S M CampbellS A Buetow
Apr 24, 2003·Health Technology Assessment : HTA·J DonovanUNKNOWN ProtecT Study Group
Jul 13, 2004·European Urology·Liliane Boccon-GibodUNKNOWN European Society of Pathology Uropathology Working Group
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric C SchneiderArnold M Epstein
Oct 20, 2005·Journal of the National Cancer Institute·Shabbir M H AlibhaiGary Naglie
Jan 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer L MalinKatherine L Kahn
Apr 3, 2007·International Journal of Radiation Oncology, Biology, Physics·Thomas N EadeAlan Pollack
Sep 4, 2007·International Journal of Radiation Oncology, Biology, Physics·Deborah A KubanAlan Pollack
Oct 9, 2007·European Urology·Axel HeidenreichUNKNOWN European Association of Urology
Jan 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mack RoachMiljenko V Pilepich
Jan 15, 2008·BJU International·Nancy L KeatingMatthew R Smith
May 20, 2008·The Journal of Urology·Shabbir M H AlibhaiGeorge Tomlinson
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin A SpencerJohn T Wei
Feb 19, 2010·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Joseph L ChinAndrew Evans
Apr 20, 2010·The Journal of Urology·Jonathan L WrightDaniel W Lin
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A HorwichUNKNOWN ESMO Guidelines Working Group
Nov 9, 2010·European Urology·Axel HeidenreichUNKNOWN European Association of Urology
Jun 16, 2011·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Nathan LawrentschukNeil E Fleshner
Jul 2, 2011·Der Urologe. Ausg. A·B LöppenbergJ Palisaar
Dec 7, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Hiroyuki FujimotoYukio Homma
Nov 28, 2012·World Journal of Urology·Luigi CormioGiuseppe Carrieri
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Jun 15, 2013·Seminars in Radiation Oncology·Ayal A AizerJason A Efstathiou
Jul 3, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A HorwichUNKNOWN ESMO Guidelines Working Group
Jul 23, 2013·BMJ Open·Valentina BianchiUNKNOWN QC3 CRC Working Group
Sep 27, 2013·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Jason P IzardJonathan L Wright
Nov 12, 2013·European Urology·Axel HeidenreichUNKNOWN European Association of Urology

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Software Mentioned

IARCcrgTools
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
Esther H ZhouSiran M Koroukian
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
M PeyromaureMembres du CCAFU
© 2022 Meta ULC. All rights reserved